The Onco’Zine Brief
The Onco’Zine Brief – a 100% independent radio broadcast/podcast concept developed for Public Radio by Sunvalley Communication – is seeking your help in funding the development of our unique, informative, broadcasts/podcast and educational programming. The Onco’Zine Brief is an educational program designed for anyone who wishes to listen to comprehensive, updated and cutting-edge news and information about cancer – from early diagnosis to treatment.
Each program is will be brought by an experienced and passionate team of medical journalists. They bundles valuable health related information, offering a continues flow of scientific and health related information – our aim is not only informs but also – where appropriate – to entertain.
The Onco’Zine Brief is generally studio based. However, a number of broadcast programs and podcast will be brought from international medical society meetings in the United States and Europe, including the annual meeting of the American Association for Cancer Research (AACR), Amercan Society of Clinical Research (ASCO), American Society of Hematology (ASH).
Each program includes interviews and stories ranging from personal stories from cancer survivors to cancer research, diagnostics, treatment & prevention and the business of cancer care.
In Arizona the program can be heard every Saturday at 1 p.m (Arizona Mountain Time) on Independent Talk 1100 KFNX, one of the top Ten Radio Stations in Arizona reaching almost 5 million people throughout Arizona. And in the United Kingdom the program is broadcast via UK Healthradio.
In addition to the regular programming, our presentation team produces many hours additional programming to be distributed as part of The Onco’Zine Dossier via iTunes.
- Public Radio Format programming, focusing on educational content;
- Targets a broad audience that encompasses the full spectrum of stakeholders;
- Highlights specific aspects of personalized medicine and targeted therapies;
Listen to the latest episodes of The Onco’Zine Brief on PRX or The Onco’Zine Brief on iHeart Radio.
Who’s listening to The Onco’Zine Brief?
- We are globally syndicated
- We average over 300,000 unique listeners per month.
- Over 90% of our listeners are aged between 25 and 64, in almost equal parts.
- 4,86% is past the current retirement age for males
- We average a 70-30% split between female and male.
For more information about sponsorship and underwriting, click here.
Copyright © 2010 -2018 Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine, Oncozine, The Onco’Zine Brief and The Onco’Zine Dossier are registered trademarks and trademarks of Sunvalley Communication around the world.
CAR-T clinical trials have demonstrated unparalleled success achieving remission rates of up to 94% in multiple hematologic malignancies…is CAR-T therapy what we’ve been waiting for? Join 18+ thought-leaders...